Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 1;47(6):1760-1771.
doi: 10.1093/ije/dyy100.

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)

Tricia L Larose  1   2 , Florence Guida  1 , Anouar Fanidi  1   3 , Arnulf Langhammer  4 , Kristian Kveem  2   4 , Victoria L Stevens  5 , Eric J Jacobs  5 , Stephanie A Smith-Warner  6   7 , Edward Giovannucci  6   7   8 , Demetrius Albanes  9 , Stephanie J Weinstein  9 , Neal D Freedman  9 , Ross Prentice  10 , Mary Pettinger  10 , Cynthia A Thomson  11 , Qiuyin Cai  12 , Jie Wu  12 , William J Blot  12   13 , Alan A Arslan  14 , Anne Zeleniuch-Jacquotte  15 , Loic Le Marchand  16 , Lynne R Wilkens  16 , Christopher A Haiman  16 , Xuehong Zhang  8 , Meir J Stampfer  6   7   8 , Allison M Hodge  17 , Graham G Giles  17   18 , Gianluca Severi  17   19   20 , Mikael Johansson  21 , Kjell Grankvist  21 , Renwei Wang  22 , Jian-Min Yuan  22   23 , Yu-Tang Gao  24 , Woon-Puay Koh  25 , Xiao-Ou Shu  26 , Wei Zheng  26 , Yong-Bing Xiang  27 , Honglan Li  28 , Qing Lan  28 , Kala Visvanathan  29 , Judith Hoffman Bolton  29 , Per Magne Ueland  30   31 , Øivind Midttun  32 , Neil Caporaso  9 , Mark Purdue  9 , Howard D Sesso  6   33   34 , Julie E Buring  6   34 , I-Min Lee  6   34 , J Michael Gaziano  33   34   35 , Jonas Manjer  36 , Hans Brunnström  37 , Paul Brennan  1 , Mattias Johansson  1
Affiliations

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)

Tricia L Larose et al. Int J Epidemiol. .

Abstract

Background: Self-reported smoking is the principal measure used to assess lung cancer risk in epidemiological studies. We evaluated if circulating cotinine-a nicotine metabolite and biomarker of recent tobacco exposure-provides additional information on lung cancer risk.

Methods: The study was conducted in the Lung Cancer Cohort Consortium (LC3) involving 20 prospective cohort studies. Pre-diagnostic serum cotinine concentrations were measured in one laboratory on 5364 lung cancer cases and 5364 individually matched controls. We used conditional logistic regression to evaluate the association between circulating cotinine and lung cancer, and assessed if cotinine provided additional risk-discriminative information compared with self-reported smoking (smoking status, smoking intensity, smoking duration), using receiver-operating characteristic (ROC) curve analysis.

Results: We observed a strong positive association between cotinine and lung cancer risk for current smokers [odds ratio (OR ) per 500 nmol/L increase in cotinine (OR500): 1.39, 95% confidence interval (CI): 1.32-1.47]. Cotinine concentrations consistent with active smoking (≥115 nmol/L) were common in former smokers (cases: 14.6%; controls: 9.2%) and rare in never smokers (cases: 2.7%; controls: 0.8%). Former and never smokers with cotinine concentrations indicative of active smoking (≥115 nmol/L) also showed increased lung cancer risk. For current smokers, the risk-discriminative performance of cotinine combined with self-reported smoking (AUCintegrated: 0.69, 95% CI: 0.68-0.71) yielded a small improvement over self-reported smoking alone (AUCsmoke: 0.66, 95% CI: 0.64-0.68) (P = 1.5x10-9).

Conclusions: Circulating cotinine concentrations are consistently associated with lung cancer risk for current smokers and provide additional risk-discriminative information compared with self-report smoking alone.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Forest plot showing odds ratios (OR) and 95% confidence intervals (95% CI) of lung cancer risk per 500 nmol/L increase in cotinine concentrations among all current smokers in the Lung Cancer Cohort Consortium (LC3). Pheterogeneity indicates differences in OR estimates between regions in the overall analysis and between men and women in the stratified analysis.
Figure 2
Figure 2
Odds ratios (OR) and 95% confidence intervals (CI) for lung cancer risk by cotinine concentration before and after adjustment for self-reported cigarettes per day (CPD) among all current smokers in the Lung Cancer Cohort Consortium (LC3). Where available, the CPD variable also included data on number of times per day the participant smoked cigars or pipes. Corresponding mean CPD for each category of cotinine concentration is given. Current smokers with cotinine levels below 115 nmol/L were used as the reference group.
Figure 3
Figure 3
Receiver operating characteristic (ROC) curve and area under the curve (AUC) for risk-discriminative performance of cotinine alone (AUCcot), self-reported smoking alone (AUCsmoke), and cotinine combined with self-reported smoking (AUCintegrated) in current smokers overall, and stratified by sex in the Lung Cancer Cohort Consortium (LC3). This analysis includes current smokers with complete data on cotinine as well as self-reported smoking status, smoking intensity and smoking duration.
Figure 4
Figure 4
Forest plot showing odds ratios (OR) and 95% confidence intervals (95% CI) of lung cancer risk for former smokers, comparing participants having circulating cotinine concentrations 5-115 nmol/L with participants having circulating cotinine concentration below 5 nmol/L. Pheterogeneity indicates differences in OR estimates between regions in the overall analysis and between men and women in the stratified analysis.
Figure 5
Figure 5
Forest plot showing odds ratios (OR) and 95% confidence intervals (95% CI) of lung cancer risk for never smokers, comparing participants with circulating cotinine concentrations 5-115 nmol/L with participants with circulating cotinine concentrations below 5 nmol/L. Pheterogeneity indicates differences in OR estimates between regions in the overall analysis and between men and women in the stratified analysis.
See this image and copyright information in PMC

References

    1. World Health Organization. Cancer Fact Sheet 2017 http://www.who.int/mediacentre/factsheets/fs297/en/ (February 2017, date last accessed).
    1. Stewart BW, Wild CP (eds). World Cancer Report 2014 Lyon, France: International Agency for Research on Cancer, 2014. - PubMed
    1. Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P.. Risk factors for lung cancer worldwide. Eur Respir J 2016;48:889–902. - PubMed
    1. Corbin M, Haslett S, Pearce N, Maule M, Greenland S.. A comparison of sensitivity-specificity imputation, direct imputation and fully Bayesian analysis to adjust for exposure misclassification when validation data are unavailable. Int J Epidemiol 2017;46:1063–72. - PubMed
    1. Benowitz NL, Jacob P 3rd.. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994;56:483–93. - PubMed

Publication types